Causaly, the AI company teaching computers to read, understand and interpret biomedical knowledge, is pleased to announce its series A fundraising round, which saw new and existing investors commit $4.8m into the company.
Latest Press Releases
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
MTF Biologics, a global nonprofit organization dedicated to saving and healing lives through organ and tissue donation, is introducing Leneva™ – Allograft Adipose Matrix and SomaGen™ Meshed – Allograft Dermal Matrix to its line of premier, innovative and effective wound care solutions.
Fresenius Kabi announced today the immediate availability in the United States of Fosaprepitant for Injection 150 mg per vial, the newest addition to the company’s generic oncology portfolio.
Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration (FDA) has approved TRIKAFTA™ (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF) in people ages 12 years and...
AptarGroup, Inc., a global leader in consumer dispensing, active packaging and drug delivery solutions, today announced that its Activ-Blister™ packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration (FDA) for a HIV prevention medicine.
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has announced the launch of its new Sartocheck® 5 Plus filter integrity tester.
Delpor, Inc., a clinical stage life sciences company that utilizes innovative technologies in order to develop once yearly therapies for chronic conditions, announced that the National Institutes of Health (NIH) has awarded the company a grant for the development of a Once-Yearly Naltrexone product for the prevention of relapse to opioid dependence.
Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved WILATE® for treatment of adults and adolescents with hemophilia A for routine prophylaxis to reduce the frequency of bleeding episodes and on demand treatment and control of bleeding episodes.
MedicaSafe, Inc. today announced a partnership with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) to provide Amneal’s generic version of Suboxone® (buprenorphine and naloxone) as part of MedicaSafe’s data-generating medication system.
DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced..